离子通道与玫瑰痤疮发病机制的研究进展

doi:10.35541/cjd.20230374

中华皮肤科杂志 ›› 2024, Vol. 57 ›› Issue (2): 174-177.doi: 10.35541/cjd.20230374

离子通道与玫瑰痤疮发病机制的研究进展

魏子妤杨勇

中国医学科学院北京协和医学院皮肤病医院遗传病中心，南京 210042

收稿日期:2023-06-27 修回日期:2023-09-15 发布日期:2024-02-01
通讯作者: 杨勇 E-mail:yyang@pumcderm.cams.cn
基金资助:
国家自然科学基金（82130091）

Role of ion channels in the pathogenesis of rosacea

Wei Ziyu, Yang Yong

Genetic Skin Disease Center, Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing 210042, China

Received:2023-06-27 Revised:2023-09-15 Published:2024-02-01
Contact: Yang Yong E-mail:yyang@pumcderm.cams.cn
Supported by:
National Natural Science Foundation of China（82130091）

摘要/Abstract

摘要： 【摘要】外界理化因素和情绪改变等会诱发玫瑰痤疮患者出现面部阵发性潮红，并伴有灼热、刺痛和瘙痒感。大量研究提示，离子通道激活后释放神经肽诱导的神经血管失调和神经源性炎症与玫瑰痤疮发病相关。本文综述近年来离子通道与玫瑰痤疮发病机制的研究进展，为以离子通道作为玫瑰痤疮的治疗靶点提供依据。

关键词: 红斑痤疮, 瞬时受体电位离子通道, 电压门控钠离子通道, 神经肽类, 神经血管, 神经源性炎症, 紧密连接蛋白

Abstract: 【Abstract】 External physicochemical factors and emotional changes often lead to intermittent facial flushing in patients with rosacea, accompanied by burning, stinging, and itching sensations. Many studies have demonstrated that neurovascular dysfunction and neurogenic inflammation induced by neuropeptides released following the activation of ion channels were associated with the occurrence of rosacea. This review summarizes research progress on the role of ion channels in the pathogenesis of rosacea and provides evidence for further research on ion channels as potential therapeutic targets for rosacea.

Key words: Rosacea, Transient receptor potential ion channel, Voltage-gated sodium channel, Neuropeptides, Neurovascular, Neurogenic inflammation, Claudin

魏子妤杨勇. 离子通道与玫瑰痤疮发病机制的研究进展[J]. 中华皮肤科杂志, 2024,57(2):174-177. doi:10.35541/cjd.20230374

Wei Ziyu, Yang Yong. Role of ion channels in the pathogenesis of rosacea[J]. Chinese Journal of Dermatology, 2024, 57(2): 174-177.doi:10.35541/cjd.20230374

参考文献 43

［1］	中华医学会皮肤性病学分会玫瑰痤疮研究中心，中国医师协会皮肤科医师分会玫瑰痤疮专业委员会. 中国玫瑰痤疮诊疗指南（2021版）［J］. 中华皮肤科杂志, 2021,54（4）:279⁃288. doi:10.35541/cjd.20201078.
［2］	Schwab VD, Sulk M, Seeliger S, et al. Neurovascular and neuroimmune aspects in the pathophysiology of rosacea［J］. J Investig Dermatol Symp Proc, 2011,15（1）:53⁃62. doi: 10.1038/jidsymp.2011.6.
［3］	Aubdool AA, Brain SD. Neurovascular aspects of skin neurogenic inflammation［J］. J Investig Dermatol Symp Proc, 2011,15（1）:33⁃39. doi: 10.1038/jidsymp.2011.8.
［4］	Mahmoud O, Soares GB, Yosipovitch G. Transient receptor potential channels and itch［J］. Int J Mol Sci, 2022,24（1）:420. doi: 10.3390/ijms24010420.
［5］	Caterina MJ, Pang Z. TRP channels in skin biology and pathophysiology［J］. Pharmaceuticals（Basel）, 2016,9（4）:77. doi: 10.3390/ph9040077.
［6］	Song Z, Chen X, Zhao Q, et al. Hair loss caused by gain⁃of⁃function mutant TRPV3 is associated with premature differentiation of follicular keratinocytes［J］. J Invest Dermatol, 2021,141（8）:1964⁃1974. doi: 10.1016/j.jid.2020.11.036.
［7］	Marek⁃Jozefowicz L, Nedoszytko B, Grochocka M, et al. Molecular mechanisms of neurogenic inflammation of the skin［J］. Int J Mol Sci, 2023,24（5）:5001. doi: 10.3390/ijms24055001.
［8］	Zhao J, Munanairi A, Liu XY, et al. PAR2 mediates itch via TRPV3 signaling in keratinocytes［J］. J Invest Dermatol, 2020,140（8）:1524⁃1532. doi: 10.1016/j.jid.2020.01.012.
［9］	Lin Z, Chen Q, Lee M, et al. Exome sequencing reveals mutations in TRPV3 as a cause of Olmsted syndrome［J］. Am J Hum Genet, 2012,90（3）:558⁃564. doi: 10.1016/j.ajhg.2012.02.006.
［10］	Zhong W, Hu L, Cao X, et al. Genotype⁃phenotype correlation of TRPV3⁃related Olmsted syndrome［J］. J Invest Dermatol, 2021,141（3）:545⁃554. doi: 10.1016/j.jid.2020.06.035.
［11］	Caterina MJ, Schumacher MA, Tominaga M, et al. The capsaicin receptor: a heat⁃activated ion channel in the pain pathway［J］. Nature, 1997,389（6653）:816⁃824. doi: 10.1038/39807.
［12］	Molot J, Sears M, Anisman H. Multiple chemical sensitivity: it′s time to catch up to the science［J］. Neurosci Biobehav Rev, 2023,151:105227. doi: 10.1016/j.neubiorev.2023.105227.
［13］	Sulk M, Seeliger S, Aubert J, et al. Distribution and expression of non⁃neuronal transient receptor potential（TRPV） ion channels in rosacea［J］. J Invest Dermatol, 2012,132（4）:1253⁃1262. doi: 10.1038/jid.2011.424.
［14］	Kim HB, Na EY, Yun SJ, et al. The effect of capsaicin on neuroinflammatory mediators of rosacea［J］. Ann Dermatol, 2022,34（4）:261⁃269. doi: 10.5021/ad.21.223.
［15］	Steinhoff M, Buddenkotte J, Aubert J, et al. Clinical, cellular, and molecular aspects in the pathophysiology of rosacea［J］. J Investig Dermatol Symp Proc, 2011,15（1）:2⁃11. doi: 10.1038/jidsymp.2011.7.
［16］	Tang L, Gao J, Cao X, et al. TRPV1 mediates itch⁃associated scratching and skin barrier dysfunction in DNFB⁃induced atopic dermatitis mice［J］. Exp Dermatol, 2022,31（3）:398⁃405. doi: 10. 1111/exd.14464.
［17］	Shin SM, Baek EJ, Oh DY, et al. Functional validation of co⁃culture model of human keratinocytes and neuronal cell line for sensitive skin by using transient receptor potential channel vanilloid subfamily member 1 antagonist［J］. Skin Res Technol, 2023,29（1）:e13275. doi: 10.1111/srt.13275.
［18］	Zhou LD, Lu YN, Liu Q, et al. Modulation of TRPV1 function by Citrus reticulata（tangerine） fruit extract for the treatment of sensitive skin［J］. J Cosmet Dermatol, 2023,22（4）:1369⁃1376. doi: 10.1111/jocd.15578.
［19］	Srour J, Bengel J, Linden T, et al. Efficacy of a skin care cream with TRPV1 inhibitor 4⁃t⁃butylcyclohexanol in the topical therapy of perioral dermatitis［J］. J Cosmet Dermatol, 2020,19（6）:1409⁃1414. doi: 10.1111/jocd.13175.
［20］	Oh S, Son M, Park J, et al. Radiofrequency irradiation modulates TRPV1⁃related burning sensation in rosacea［J］. Molecules, 2021,26（5）:1424. doi: 10.3390/molecules26051424.
［21］	Mascarenhas NL, Wang Z, Chang YL, et al. TRPV4 mediates mast cell activation in cathelicidin⁃induced rosacea inflammation［J］. J Invest Dermatol, 2017,137（4）:972⁃975. doi: 10.1016/j.jid.2016.10.046.
［22］	Wang LN, Wang XZ, Li YJ, et al. Activation of subcutaneous mast cells in acupuncture points triggers analgesia［J］. Cells, 2022,11（5）:809. doi: 10.3390/cells11050809.
［23］	Woźniak E, Owczarczyk⁃Saczonek A, Lange M, et al. The role of mast cells in the induction and maintenance of inflammation in selected skin diseases［J］. Int J Mol Sci, 2023,24（8）:7021. doi: 10.3390/ijms24087021.
［24］	Muto Y, Wang Z, Vanderberghe M, et al. Mast cells are key mediators of cathelicidin⁃initiated skin inflammation in rosacea［J］. J Invest Dermatol, 2014,134（11）:2728⁃2736. doi: 10.1038/jid.2014.222.
［25］	Peier AM, Reeve AJ, Andersson DA, et al. A heat⁃sensitive TRP channel expressed in keratinocytes［J］. Science, 2002,296（5575）:2046⁃2049. doi: 10.1126/science.1073140.
［26］	Um JY, Kang SY, Kim HJ, et al. Transient receptor potential vanilloid⁃3（TRPV3） channel induces dermal fibrosis via the TRPV3/TSLP/Smad2/3 pathways in dermal fibroblasts［J］. J Dermatol Sci, 2020,97（2）:117⁃124. doi: 10.1016/j.jdermsci.2019. 12.011.
［27］	Fromy B, Josset⁃Lamaugarny A, Aimond G, et al. Disruption of TRPV3 impairs heat⁃evoked vasodilation and thermoregulation: a critical role of CGRP［J］. J Invest Dermatol, 2018,138（3）:688⁃696. doi: 10.1016/j.jid.2017.10.006.
［28］	Huang Y, Yan S, Xie H, et al. Health related quality of life of rosacea patients in China assessed by dermatology life quality index and willingness to pay［J］. Patient Prefer Adherence, 2022,16:659⁃670. doi: 10.2147/PPA.S345258.
［29］	Fan J, Hu L, Yue Z, et al. Structural basis of TRPV3 inhibition by an antagonist［J］. Nat Chem Biol, 2023,19（1）:81⁃90. doi: 10. 1038/s41589⁃022⁃01166⁃5.
［30］	Qi H, Shi Y, Wu H, et al. Inhibition of temperature⁃sensitive TRPV3 channel by two natural isochlorogenic acid isomers for alleviation of dermatitis and chronic pruritus［J］. Acta Pharm Sin B, 2022,12（2）:723⁃734. doi: 10.1016/j.apsb.2021.08.002.
［31］	Han Y, Luo A, Kamau PM, et al. A plant⁃derived TRPV3 inhibitor suppresses pain and itch［J］. Br J Pharmacol, 2021,178（7）:1669⁃1683. doi: 10.1111/bph.15390.
［32］	Lee WJ, Shim WS. Cutaneous neuroimmune interactions of TSLP and TRPV4 play pivotal roles in dry skin⁃induced pruritus［J］. Front Immunol, 2021,12:772941. doi: 10.3389/fimmu.2021. 772941.
［33］	Zhou X, Su Y, Wu S, et al. The temperature⁃sensitive receptors TRPV4 and TRPM8 have important roles in the pruritus of rosacea［J］. J Dermatol Sci, 2022,108（2）:68⁃76. doi: 10.1016/j.jdermsci.2022.11.004.
［34］	Maglie R, Souza Monteiro de Araujo D, Antiga E, et al. The role of TRPA1 in skin physiology and pathology［J］. Int J Mol Sci, 2021,22（6）:3065. doi: 10.3390/ijms22063065.
［35］	Kataoka Y, Kenny GP, Nishiyasu T, et al. TRPA1 channel activation with cinnamaldehyde induces cutaneous vasodilation through NOS, but not COX and KCa channel, mechanisms in humans［J］. J Cardiovasc Pharmacol, 2022,79（3）:375⁃382. doi: 10.1097/FJC.0000000000001188.
［36］	Yin Y, Zhang F, Feng S, et al. Activation mechanism of the mouse cold⁃sensing TRPM8 channel by cooling agonist and PIP（2）［J］. Science, 2022,378（6616）:eadd1268. doi: 10.1126/science. add1268.
［37］	Huang SS, Su HH, Chien SY, et al. Activation of peripheral TRPM8 mitigates ischemic stroke by topically applied menthol［J］. J Neuroinflammation, 2022,19（1）:192. doi: 10.1186/s12974⁃ 022⁃02553⁃4.
［38］	Martinowich K, Das D, Sripathy SR, et al. Evaluation of Na（v）1.8 as a therapeutic target for Pitt Hopkins syndrome［J］. Mol Psychiatry, 2023,28（1）:76⁃82. doi: 10.1038/s41380⁃022⁃01811⁃4.
［39］	Sun PY, Li HG, Xu QY, et al. Lidocaine alleviates inflammation and pruritus in atopic dermatitis by blocking different population of sensory neurons［J］. Br J Pharmacol, 2023,180（10）:1339⁃1361. doi: 10.1111/bph.16012.
［40］	Zhang Y, Li Y, Zhou L, et al. Nav1.8 in keratinocytes contributes to ROS⁃mediated inflammation in inflammatory skin diseases［J］. Redox Biol, 2022,55:102427. doi: 10.1016/j.redox.2022.10 2427.
［41］	Tsukita S, Tanaka H, Tamura A. The claudins: from tight junctions to biological systems［J］. Trends Biochem Sci, 2019,44（2）:141⁃152. doi: 10.1016/j.tibs.2018.09.008.
［42］	Kirschner N, Rosenthal R, Furuse M, et al. Contribution of tight junction proteins to ion, macromolecule, and water barrier in keratinocytes［J］. J Invest Dermatol, 2013,133（5）:1161⁃1169. doi: 10.1038/jid.2012.507.
［43］	Deng Z, Chen M, Xie H, et al. Claudin reduction may relate to an impaired skin barrier in rosacea［J］. J Dermatol, 2019,46（4）:314⁃321. doi: 10.1111/1346⁃8138.14792.

[1]	张悦陶梦李敏姜沛彧刘韵祎刘乙萱潘婼芯许阳. 玫瑰痤疮病情评价标准研究进展[J]. 中华皮肤科杂志, 2024, 57(2): 182-185.
[2]	潘婼芯顾多多张悦李敏陶梦许阳. 代谢组学在玫瑰痤疮研究中的应用进展[J]. 中华皮肤科杂志, 2024, 57(2): 178-181.
[3]	刘亭微孟潇琦顾多多潘婼芯张悦许阳. 玫瑰痤疮发病机制的研究进展[J]. 中华皮肤科杂志, 2024, 57(2): 186-190.
[4]	李吉谢红付. 如何避免玫瑰痤疮的误诊[J]. 中华皮肤科杂志, 2024, 57(2): 119-122.
[5]	蒋献宋德宇. [开放获取] 从心身医学视角认识玫瑰痤疮[J]. 中华皮肤科杂志, 2024, 57(2): 123-126.
[6]	那君李若瑜仲少敏杨莉吴艳. 玫瑰痤疮真实世界诊疗现状调查分析[J]. 中华皮肤科杂志, 2024, 57(2): 127-133.
[7]	马光荣谢红付刘家双周钟莲周淞麒黄莹雪李吉. 玫瑰痤疮患者小肠细菌过度生长情况调查及临床特征分析[J]. 中华皮肤科杂志, 2024, 57(2): 134-140.
[8]	张晓东汪蔓雅朱英杰骆天德刘小明. 荧光染色法在面部皮肤蠕形螨检查中的应用评估[J]. 中华皮肤科杂志, 2023, 56(8): 766-769.
[9]	陶梦李敏刘乙萱刘韵祎姜沛彧张嘉文南宇晴许阳. 玫瑰痤疮与精神神经性疾病相关性研究进展[J]. 中华皮肤科杂志, 2023, 56(7): 693-697.
[10]	米淑宏余艳琴郝金奇李薇张杨贾喜梅黄毓娴孙怀玉石继海. 丘疹脓疱型玫瑰痤疮患者皮肤高频超声联合彩色多普勒血流成像的特征[J]. 中华皮肤科杂志, 2023, 56(6): 540-544.
[11]	李嘉祺叶枫鞠强. 表皮葡萄球菌共生性稳态与皮肤疾病[J]. 中华皮肤科杂志, 2023, 56(5): 459-462.
[12]	李容张家安陈崑. 玫瑰痤疮光电疗法研究进展[J]. 中华皮肤科杂志, 2023, 56(5): 468-470.
[13]	王小燕张嘉文刘韵祎刘乙萱姜沛彧李敏陶梦许阳. 玫瑰痤疮的皮肤影像学和无创检测技术相关进展[J]. 中华皮肤科杂志, 2023, 56(4): 361-364.
[14]	王亚玲谢红付李吉汪犇. JAK-STAT信号通路与玫瑰痤疮[J]. 中华皮肤科杂志, 2023, 56(2): 169-172.
[15]	孙静徐英男林彤薛劲松. 重度玫瑰痤疮眼型28例眼部损害临床治疗结局分析[J]. 中华皮肤科杂志, 2023, 56(2): 142-145.

离子通道与玫瑰痤疮发病机制的研究进展

Role of ion channels in the pathogenesis of rosacea

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 43

相关文章 15

Metrics

本文评价

推荐阅读 10